Fingerprint
Dive into the research topics of 'QTc Interval-Prolonging Medications Among Patients With Lung Cancer: Implications for Clinical Trial Eligibility and Clinical Care'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
QTc Interval-Prolonging Medications Among Patients With Lung Cancer: Implications for Clinical Trial Eligibility and Clinical Care
Tri Le, Hui Yang, Sawsan Rashdan, Mark S. Link, Vlad G. Zaha, Carlos Alvarez, David E. Gerber
Research output: Contribution to journal › Article › peer-review
3
Scopus
citations